What are the pitfalls when it comes to navigating life sciences and pharma patents? Our experts will be exploring definitions and clinical trials in our upcoming webinar on Wednesday 30 October at 13:30-14:30 GMT | 14:30-15:30 GMT | 15:30-16:30 CEST to help you avoid those stumbling blocks.
Our experts will be covering:
- Clinical trial case law at the EPO – Valuable inventions in the pharmaceutical field can be generated when clinical trials are about to begin or have already begun, such as inventions relating to dosage regimes and treating patient sub-populations. The EPO has developed a body of case law relating to the patentability such inventions when clinical trial information has already been published. We'll give an overview of and commentary on the case law in this area.
- Drafting in light of G1/24 – Questions have been referred to the Enlarged Board of Appeal which focus on the relevance of definitions in a patent application when considering the patentability of the claims. We will be looking into the questions posed and considering best practices using definitions in drafting, how a definition may be used to open a door to oppose a patent and the importance of definitions in rapidly growing technology areas.
Host
Michael Ford – Partner, UK and European Patent Attorney
Speakers
Joseph Lenthall – Partner, UK and European Patent Attorney
Catherine Coombes – Partner, UK and European Patent Attorney